Abon Pharmaceuticals

Manufacturing · New York, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

House Road Building B 100 Red School, Ch...

Revenue

$6.7 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1

About Abon Pharmaceuticals

Abon Pharmaceuticals, LLC is a specialty pharmaceutical company that focuses on developing a wide range of pharmaceutical products, including complex generics and proprietary formulations in injectable and oral dosage forms. The company emphasizes a science-based approach to product development, integrating product quality through formulation and process design. Abon utilizes modern technology and scientific methods to enhance dosage form efficiency and improve patient compliance. With recent FDA approval for a generic version of Carafate, Abon is poised to launch this complex product in the market.Explore more
Abon Pharmaceuticals's Social MediaPopular SearchesAbon Pharmaceuticals LLCAbon LLCAmbotan Pharma LLCAlban Pharma LLCSIC Code 28,283NAICS Code 32,325Show more

Abon Pharmaceuticals Org Chart

SA
United States flag for contact location.

President & Chief Executive Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email
GK
United States flag for contact location.

Executive VP, Quality & Analytical Services

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
WH
United States flag for contact location.

Executive Director

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Abon Pharmaceuticals your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Abon Pharmaceuticals

Compare insights from companies similar to Abon Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Abon Pharmaceuticals

$6.7M
11-50
Private
<$5M
2009
SA
Salah AhmedPresident & CEO
$13.1M
11-50
Private
<$5M
2017
RF
Richard FergusonDirector, Production Operations
$9.4M
11-50
Private
<$5M
2014
KH
Karen HanleyExecutive Director, Business Development
$6.3M
11-50
Private
<$5M
2007
PB
Pamela BaxterDirector, Quality
$6M
51-200
Private
<$5M
2001
<$5M
1-10
Private
-
2014
JH
Jared HeimovitzManager, Business Development & Marketing
<$5M
1-10
Private
-
-
N/A
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

Abon Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

Abon Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Abon Pharmaceuticals.

Abon Pharmaceuticals financials insights

Gather financial insights about Abon Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.

2020

Debt

$350K

See All Abon Pharmaceuticals's Financials Insights

Abon Pharmaceuticals Tech Stack

A closer look at the technologies used by Abon Pharmaceuticals

Top Manufacturing Companies

Frequently Asked Questions Regarding Abon Pharmaceuticals

What is Abon Pharmaceuticals's official website?
Abon Pharmaceuticals's official website is www.abonpharma.com
What is Abon Pharmaceuticals's Revenue?
Abon Pharmaceuticals's revenue is $6.7 Million
What is Abon Pharmaceuticals's SIC code?
Abon Pharmaceuticals's SIC: 28,283
What is Abon Pharmaceuticals's NAICS code?
Abon Pharmaceuticals's NAICS: 32,325
How many employees does Abon Pharmaceuticals have?
Abon Pharmaceuticals has 11-50 employees
What industry does Abon Pharmaceuticals belong to?
Abon Pharmaceuticals is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is Abon Pharmaceuticals competition?
Abon Pharmaceuticals top competitors include: WES Pharma, CMC Pharmaceuticals, Tedor Pharma, RanX Pharmaceuticals
What technology does Abon Pharmaceuticals use?
Some of the popular technologies that Abon Pharmaceuticals uses are: Microsoft IIS, Cloudflare CDN, Sucuri WAF, Sucuri Website Security
What does Abon Pharmaceuticals do?

Abon Pharmaceuticals, LLC is a specialty pharmaceutical company that focuses on developing a wide range of pharmaceutical products, including complex generics and proprietary formulations in injectable and oral dosage forms. The company emphasizes a science-based approach to product development, integrating product quality through formulation and p... rocess design. Abon utilizes modern technology and scientific methods to enhance dosage form efficiency and improve patient compliance. With recent FDA approval for a generic version of Carafate, Abon is poised to launch this complex product in the market.Read More

What are Abon Pharmaceuticals social media links?
Abon Pharmaceuticals Linkedin page
Is Abon Pharmaceuticals a public company?
Abon Pharmaceuticals is private company therefore does not currently have an official ticker symbol
See more information about Abon Pharmaceuticals

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.